Results

FDA Approves Cuvposa for Chronic Drooling in Children

Thu, 2010-07-29 14:07 — Anonymous

ROCKVILLE, Md., July 28, 2010--The U.S. Food and Drug
Administration today approved Cuvposa (glycopyrrolate) Oral
Solution to treat chronic severe drooling caused by neurologic
disorders in children ages 3 years to 16 years.
Drooling is normal...

...
Source - Read More  

More on Sciencestage.com

    More on Wikipedia

      Related Videos

      • UC Irvine's Hans Keirstead Discusses Stem Cell Research & FDA Approval (2)
        UC Irvine's Hans Keirstead Discusses Stem Cell Research & FDA Approval (2) UC Irvine neuroscientist Hans Keirstead discusses his research and FDA approval of world's first embryonic stem cell study in humans. Video by Kerrin Piche S... From: ucirvine Views: 231 1 ratings Time: 02:57 More in Science & Technology

      More on answers.yahoo.com

        More on Pubmed

          More on Answers.com